ABOUT Variantyx

We see whole genome sequencing (WGS) as the standard of genomic diagnostic care, and are working to make whole genome testing broadly accessible to patients with rare genetic diseases.

 

Why whole genome sequencing? It provides the most comprehensive view of an individual’s genome. Unlike panels and exome sequencing which target specific regions comprising 1.5% or less of an individual’s DNA, WGS covers the entire known genome, including the mitochondrial genome. It enables identification of single nucleotide variants, indels and structural variants, including CNVs and tandem repeats, in data from a single sequencing run. This means that variants relevant to a patient’s diagnosis are less likely to be missed. At the same time, use of in silico panels enables targeted analysis when desired. Fewer sequencing runs and individual tests are performed, yet the data can be reanalyzed at any time as new information becomes available. The result is a higher diagnostic yield and fast turnaround time combined with lower overall cost for the test provider, the payer and the patient.

 

Our Genomic Intelligence® diagnostic platform makes WGS accessible through a combination of integration with world-leading sequencing partners, automated data analysis with clinical report generation and collaborative diagnostic services performed by our board-certified medical geneticists.

 

At Variantyx we’re committed to working with clinicians, labs and hospitals alike to enable fast, high quality diagnosis at reduced cost. Let’s work together to raise the standard of diagnostic care.

Meet Our Team

Varianty Inc, headquartered in Framingham, Massachusetts, was founded in 2014. Our team brings extensive expertise across disciplines critical to solving the challenge of making WGS accessible and affordable including medicine, clinical research, bioinformatics, engineering, information technology, laboratory and service operations and executive management.

 

Haim

Haim Neerman

CEO


> Full Bio

Haim's career spans over 20 years of technology entrepreneurship. Prior to co-founding Variantyx, Haim cofounded Credorax Inc. – a global credit card acquiring bank , Fabrix systems (acquired by Ericson), Bandwiz Inc. and Actil Ltd. Haim is a physics, math and computer science graduate of the Talpiot program / Hebrew university of Jerusalem

Tomer Jackman

Tomer Jackman

COO


> Full Bio

Tomer serves as the Chief Operating Officer of Variantyx and is responsible for delivering services to customers. This includes day to day operations such as supply chain management, customer care, and above all, productivity. Prior to co-founding Variantyx, Tomer was responsible for hardware development operations in Pivotal/Greenplum division of EMC2 where he helped develop server clusters for "Massive Parallel Processing" databases. This followed a decade with EMC2 in several hardware engineering roles, and work in R&D with HP/Indigo. He holds a high-tech MBA from Northeastern University in Boston, and a BSc in Electrical Engineering from Tel-Aviv University.

Muthu

Muthu Meyyappan
PhD

CCO


> Full Bio

Muthu serves as the Chief Commercial Officer and is responsible for the overall commercial strategy including sales, marketing and customer support. His primary focus is to drive market adoption of Variantyx’s products and services and to drive revenue growth. Prior to joining Variantyx, Muthu was the Vice President of Advanced Genomics Commercial Operations for QIAGEN where he was responsible for worldwide revenue for the bioinformatics franchise. He has more than 17+ years’ experience in customer facing environments within the pharmaceutical, biotech, academic research and clinical sectors where he represented Incyte Genomics and was the Chief Business Officer for BIOBASE Corporation. Muthu holds a Bachelor’s degree in Biotechnology from the Rochester Institute of Technology, New York and a PhD in Cancer Biology from the Southern Alberta Cancer Research Center, in Calgary, Canada.

Yaron Rachmany

Yaron Rachmany

CIO


> Full Bio

Yaron Rachmany oversees Variantyx’ IT system and Business processes. Prior to joining Variantyx, Yaron served as Director of Systems Operations and as a Director of IT Applications at Semtech Corporation (NASDAQ: SMTC). Prior to Semtech Yaron held the VP of Information systems position with Credorax. Prior to Credorax, Yaron held senior Information Systems positions with Microsemi MSCC (NASDAQ, Intel INTC (NASDAQ) and ECI Telecom.

Yaron holds a M.Sc. and a B.Sc. in industrial engineering and Management (specialized in Information Systems) from Ben Gurion University in Israel.

> Full Bio

Haim's career spans over 20 years of technology entrepreneurship. Prior to co-founding Variantyx, Haim cofounded Credorax Inc. – a global credit card acquiring bank , Fabrix systems (acquired by Ericson), Bandwiz Inc. and Actil Ltd. Haim is a physics, math and computer science graduate of the Talpiot program / Hebrew university of Jerusalem

    
 >Full Bio

Tomer serves as the Chief Operating Officer of Variantyx and is responsible for delivering services to customers. This includes day to day operations such as supply chain management, customer care, and above all, productivity. Prior to co-founding Variantyx, Tomer was responsible for hardware development operations in Pivotal/Greenplum division of EMC2 where he helped develop server clusters for "Massive Parallel Processing" databases. This followed a decade with EMC2 in several hardware engineering roles, and work in R&D with HP/Indigo. He holds a high-tech MBA from Northeastern University in Boston, and a BSc in Electrical Engineering from Tel-Aviv University.

        >Full Bio

Muthu serves as the Chief Commercial Officer and is responsible for the overall commercial strategy including sales, marketing and customer support. His primary focus is to drive market adoption of Variantyx’s products and services and to drive revenue growth. Prior to joining Variantyx, Muthu was the Vice President of Advanced Genomics Commercial Operations for QIAGEN where he was responsible for worldwide revenue for the bioinformatics franchise. He has more than 17+ years’ experience in customer facing environments within the pharmaceutical, biotech, academic research and clinical sectors where he represented Incyte Genomics and was the Chief Business Officer for BIOBASE Corporation. Muthu holds a Bachelor’s degree in Biotechnology from the Rochester Institute of Technology, New York and a PhD in Cancer Biology from the Southern Alberta Cancer Research Center, in Calgary, Canada.

        >Full Bio

Yaron Rachmany oversees Variantyx’ IT system and Business processes. Prior to joining Variantyx, Yaron served as Director of Systems Operations and as a Director of IT Applications at Semtech Corporation (NASDAQ: SMTC). Prior to Semtech Yaron held the VP of Information systems position with Credorax. Prior to Credorax, Yaron held senior Information Systems positions with Microsemi MSCC (NASDAQ, Intel INTC (NASDAQ) and ECI Telecom.

Yaron holds a M.Sc. and a B.Sc. in industrial engineering and Management (specialized in Information Systems) from Ben Gurion University in Israel.

> Full Bio

Haim's career spans over 20 years of technology entrepreneurship. Prior to co-founding Variantyx, Haim cofounded Credorax Inc. – a global credit card acquiring bank , Fabrix systems (acquired by Ericson), Bandwiz Inc. and Actil Ltd. Haim is a physics, math and computer science graduate of the Talpiot program / Hebrew university of Jerusalem

> Full Bio

Tomer serves as the Chief Operating Officer of Variantyx and is responsible for delivering services to customers. This includes day to day operations such as supply chain management, customer care, and above all, productivity. Prior to co-founding Variantyx, Tomer was responsible for hardware development operations in Pivotal/Greenplum division of EMC2 where he helped develop server clusters for "Massive Parallel Processing" databases. This followed a decade with EMC2 in several hardware engineering roles, and work in R&D with HP/Indigo. He holds a high-tech MBA from Northeastern University in Boston, and a BSc in Electrical Engineering from Tel-Aviv University.

> FullBio

Muthu serves as the Chief Commercial Officer and is responsible for the overall commercial strategy including sales, marketing and customer support. His primary focus is to drive market adoption of Variantyx’s products and services and to drive revenue growth. Prior to joining Variantyx, Muthu was the Vice President of Advanced Genomics Commercial Operations for QIAGEN where he was responsible for worldwide revenue for the bioinformatics franchise. He has more than 17+ years’ experience in customer facing environments within the pharmaceutical, biotech, academic research and clinical sectors where he represented Incyte Genomics and was the Chief Business Officer for BIOBASE Corporation. Muthu holds a Bachelor’s degree in Biotechnology from the Rochester Institute of Technology, New York and a PhD in Cancer Biology from the Southern Alberta Cancer Research Center, in Calgary, Canada.

      > Full Bio

Yaron Rachmany oversees Variantyx’ IT system and Business processes. Prior to joining Variantyx, Yaron served as Director of Systems Operations and as a Director of IT Applications at Semtech Corporation (NASDAQ: SMTC). Prior to Semtech Yaron held the VP of Information systems position with Credorax. Prior to Credorax, Yaron held senior Information Systems positions with Microsemi MSCC (NASDAQ, Intel INTC (NASDAQ) and ECI Telecom.

Yaron holds a M.Sc. and a B.Sc. in industrial engineering and Management (specialized in Information Systems) from Ben Gurion University in Israel.

Allan J Fisher

Allan J. Fisher
MD,FACOG,FACMG

Medical Director



> Full Bio

Allan J Fisher, MD graduated his professional studies at St. Louis University School of Medicine, St. Louis, Missouri. He proceeded to complete his postgraduate work at Emory University Affiliated Hospitals in Atlanta, Georgia, for his Gynecology and Obstetrics residency, Maternal Fetal Medicine Fellowship, and Medical Genetics Fellowship, which he is Boarded for all three. His experiences include many years of academic and clinical medicine, mostly in the Northeast. Leadership roles of Directorships for Maternal Fetal Medicine and Perinatal / Reproductive Genetics and Medical Director as well as Chairs to multiple Volunteer Organizations. He has over 25 years experience of teaching students, residents, and fellows and has published multiple articles and chapters. He is a member to many outside Professional and Medical organizations and Boards, including two State Medical Boards. He has close to 20 years experience as an active volunteer member to the March of Dimes, New Jersey Chapter, and was presented the Franklin Award due to his activism in launching the preterm delivery campaign in New Jersey.

His primary medical interests include Prenatal Genetics and Diagnosis, Fetal Dysmorphology, Genetic Screening, Ultrasound (3D/4D, Fetal Echocardiography, Detailed Cranial Sonography). Most recent publications include the uses of Microarrays in Prenatal Diagnosis involving the largest cohort studied of over 5000 fetuses.

NaomiMeeks

Naomi Meeks
MD, FAAP, FACMG

Lab Director


> Full Bio

Naomi attended medical school at the University of Iowa Carver College of Medicine and completed a Pediatrics residency at Indiana University School of Medicine/Riley Hospital for Children.  After residency, Naomi received training in Clinical Genetics and Molecular Genetics at the University of Colorado and is board certified in Pediatrics, Clinical Genetics & Molecular Genetics.  Naomi’s clinical practice has included Pediatric Genetics with specialty interests including 22q11.2 Deletion Syndrome and Differences of Sexual Development.  Naomi also serves as a medical director for the Children's Hospital Colorado Molecular Genetics Laboratory and is involved in teaching and research.

JenniferHogan

Jennifer Hogan PhD

VP of Marketing


> Full Bio

Jennifer serves as the VP of Marketing and is responsible for content strategy and tactical execution driving awareness, education and lead generation for Variantyx’s products and services. Prior to joining Variantyx, Jennifer led product management and product marketing for the genetic disease portfolio within QIAGEN’s bioinformatics business area. She has many years of experience leading customer-focused product development of biological databases and software at QIAGEN, BIOBASE Corporation and Incyte Genomics. Jennifer received her PhD in Biochemistry and Molecular Biology from the University of New Hampshire studying developmental genetics in a model organism system. 

> Full Bio

Jennifer serves as the VP of Marketing and is responsible for content strategy and tactical execution driving awareness, education and lead generation for Variantyx’s products and services. Prior to joining Variantyx, Jennifer led product management and product marketing for the genetic disease portfolio within QIAGEN’s bioinformatics business area. She has many years of experience leading customer-focused product development of biological databases and software at QIAGEN, BIOBASE Corporation and Incyte Genomics. Jennifer received her PhD in Biochemistry and Molecular Biology from the University of New Hampshire studying developmental genetics in a model organism system. 

> Full Bio

Allan J Fisher, MD graduated his professional studies at St. Louis University School of Medicine, St. Louis, Missouri. He proceeded to complete his postgraduate work at Emory University Affiliated Hospitals in Atlanta, Georgia, for his Gynecology and Obstetrics residency, Maternal Fetal Medicine Fellowship, and Medical Genetics Fellowship, which he is Boarded for all three. His experiences include many years of academic and clinical medicine, mostly in the Northeast. Leadership roles of Directorships for Maternal Fetal Medicine and Perinatal / Reproductive Genetics and Medical Director as well as Chairs to multiple Volunteer Organizations. He has over 25 years experience of teaching students, residents, and fellows and has published multiple articles and chapters. He is a member to many outside Professional and Medical organizations and Boards, including two State Medical Boards. He has close to 20 years experience as an active volunteer member to the March of Dimes, New Jersey Chapter, and was presented the Franklin Award due to his activism in launching the preterm delivery campaign in New Jersey.

His primary medical interests include Prenatal Genetics and Diagnosis, Fetal Dysmorphology, Genetic Screening, Ultrasound (3D/4D, Fetal Echocardiography, Detailed Cranial Sonography). Most recent publications include the uses of Microarrays in Prenatal Diagnosis involving the largest cohort studied of over 5000 fetuses.

   
  >Full Bio

Naomi attended medical school at the University of Iowa Carver College of Medicine and completed a Pediatrics residency at Indiana University School of Medicine/Riley Hospital for Children.  After residency, Naomi received training in Clinical Genetics and Molecular Genetics at the University of Colorado and is board certified in Pediatrics, Clinical Genetics & Molecular Genetics.  Naomi’s clinical practice has included Pediatric Genetics with specialty interests including 22q11.2 Deletion Syndrome and Differences of Sexual Development.  Naomi also serves as a medical director for the Children's Hospital Colorado Molecular Genetics Laboratory and is involved in teaching and research.

        >Full Bio

Jennifer serves as the VP of Marketing and is responsible for content strategy and tactical execution driving awareness, education and lead generation for Variantyx’s products and services. Prior to joining Variantyx, Jennifer led product management and product marketing for the genetic disease portfolio within QIAGEN’s bioinformatics business area. She has many years of experience leading customer-focused product development of biological databases and software at QIAGEN, BIOBASE Corporation and Incyte Genomics. Jennifer received her PhD in Biochemistry and Molecular Biology from the University of New Hampshire studying developmental genetics in a model organism system. 

> Full bio

Allan J Fisher, MD graduated his professional studies at St. Louis University School of Medicine, St. Louis, Missouri. He proceeded to complete his postgraduate work at Emory University Affiliated Hospitals in Atlanta, Georgia, for his Gynecology and Obstetrics residency, Maternal Fetal Medicine Fellowship, and Medical Genetics Fellowship, which he is Boarded for all three. His experiences include many years of academic and clinical medicine, mostly in the Northeast. Leadership roles of Directorships for Maternal Fetal Medicine and Perinatal / Reproductive Genetics and Medical Director as well as Chairs to multiple Volunteer Organizations. He has over 25 years experience of teaching students, residents, and fellows and has published multiple articles and chapters. He is a member to many outside Professional and Medical organizations and Boards, including two State Medical Boards. He has close to 20 years experience as an active volunteer member to the March of Dimes, New Jersey Chapter, and was presented the Franklin Award due to his activism in launching the preterm delivery campaign in New Jersey.

His primary medical interests include Prenatal Genetics and Diagnosis, Fetal Dysmorphology, Genetic Screening, Ultrasound (3D/4D, Fetal Echocardiography, Detailed Cranial Sonography). Most recent publications include the uses of Microarrays in Prenatal Diagnosis involving the largest cohort studied of over 5000 fetuses.


 

> Full Bio

Naomi attended medical school at the University of Iowa Carver College of Medicine and completed a Pediatrics residency at Indiana University School of Medicine/Riley Hospital for Children.  After residency, Naomi received training in Clinical Genetics and Molecular Genetics at the University of Colorado and is board certified in Pediatrics, Clinical Genetics & Molecular Genetics.  Naomi’s clinical practice has included Pediatric Genetics with specialty interests including 22q11.2 Deletion Syndrome and Differences of Sexual Development.  Naomi also serves as a medical director for the Children's Hospital Colorado Molecular Genetics Laboratory and is involved in teaching and research.

> Full Bio

Jennifer serves as the VP of Marketing and is responsible for content strategy and tactical execution driving awareness, education and lead generation for Variantyx’s products and services. Prior to joining Variantyx, Jennifer led product management and product marketing for the genetic disease portfolio within QIAGEN’s bioinformatics business area. She has many years of experience leading customer-focused product development of biological databases and software at QIAGEN, BIOBASE Corporation and Incyte Genomics. Jennifer received her PhD in Biochemistry and Molecular Biology from the University of New Hampshire studying developmental genetics in a model organism system. 

Noam Shomron

Noam Shomron
PhD

CSO



> Full Bio

Dr Noam Shomron heads the Genomic Intelligence Research Laboratory at the Faculty of Medicine at Tel Aviv University. Dr Shomron leads a multidisciplinary team of scientists consisting of biologists, physicians, engineers, bioinformaticians and mathematicians. The team aims to deepen our understanding of the development of diseases in order to generate a significant impact through translating ideas into clinical reality.

Dr Shomron is also the Editor-in-Chief of ‘Genetics Research’ (Cambridge University Press); Director of Rare Genomics Israel a non-profit organization that assists children and families with undiagnosed genetic disorders; Academic Director of ScienceAbroad; and Co-founder of several Biotech companies.

Alexander Kaplun

Alexander Kaplun
PhD

Dir. Product Management

> Full Bio

Dr. Kaplun is among the developers of comprehensive pharmacogenomic database PGMD and other tools and databases aiming to satisfy the growing demand for clinical genomic analysis. He is an author of over 20 peer-reviewed publications.

Before joining Variantyx, Dr Kaplun served as Senior Scientist and Associate Manager of Advanced Genomics at QIAGEN Bioinformatics. During his postdoctoral training he was involved in identification of novel regulatory mechanisms of signal transduction in cancer, factors affecting metastasis and in investigation of longevity mechanisms at Karmanos Cancer Institute. He received his PhD summa cum laude from Ben-Gurion University of the Negev.

Shira Modai

Shira Modai
PhD

Dir. Clinical Operations

> Full Bio

Prior to joining Variantyx, Dr. Shira Modai managed the genomic center of Tel Aviv university. Shira holds a B.Sc in Biotechnology and Food engineering, an M.Sc. in Medical science specializing in Virology and Ph.D. in biology from Tel Aviv University focusing on miRNAs expressed from viral genomes and the interplay with host miRNAs and genes. The Ph.D. thesis was based on the first Next Generation Sequencing runs done in TAU Genomic lab utilizing the Illumina Genome Analyzer IIX sequencer. Shira’s responsibility with Variantyx includes communication with the clinical community (clinicians and hospitals) throughout the lifecycle of a test providing a single point of contact with Variantyx

> Full bio

Dr Noam Shomron heads the Genomic Intelligence Research Laboratory at the Faculty of Medicine at Tel Aviv University. Dr Shomron leads a multidisciplinary team of scientists consisting of biologists, physicians, engineers, bioinformaticians and mathematicians. The team aims to deepen our understanding of the development of diseases in order to generate a significant impact through translating ideas into clinical reality.

Dr Shomron is also the Editor-in-Chief of ‘Genetics Research’ (Cambridge University Press); Director of Rare Genomics Israel a non-profit organization that assists children and families with undiagnosed genetic disorders; Academic Director of ScienceAbroad; and Co-founder of several Biotech companies.

  
  >Full Bio

Dr. Kaplun is among the developers of comprehensive pharmacogenomic database PGMD and other tools and databases aiming to satisfy the growing demand for clinical genomic analysis. He is an author of over 20 peer-reviewed publications.

Before joining Variantyx, Dr Kaplun served as Senior Scientist and Associate Manager of Advanced Genomics at QIAGEN Bioinformatics. During his postdoctoral training he was involved in identification of novel regulatory mechanisms of signal transduction in cancer, factors affecting metastasis and in investigation of longevity mechanisms at Karmanos Cancer Institute. He received his PhD summa cum laude from Ben-Gurion University of the Negev.

        >Full Bio

Prior to joining Variantyx, Dr. Shira Modai managed the genomic center of Tel Aviv university. Shira holds a B.Sc in Biotechnology and Food engineering, an M.Sc. in Medical science specializing in Virology and Ph.D. in biology from Tel Aviv University focusing on miRNAs expressed from viral genomes and the interplay with host miRNAs and genes. The Ph.D. thesis was based on the first Next Generation Sequencing runs done in TAU Genomic lab utilizing the Illumina Genome Analyzer IIX sequencer. Shira’s responsibility with Variantyx includes communication with the clinical community (clinicians and hospitals) throughout the lifecycle of a test providing a single point of contact with Variantyx

> Full Bio

Dr Noam Shomron heads the Genomic Intelligence Research Laboratory at the Faculty of Medicine at Tel Aviv University. Dr Shomron leads a multidisciplinary team of scientists consisting of biologists, physicians, engineers, bioinformaticians and mathematicians. The team aims to deepen our understanding of the development of diseases in order to generate a significant impact through translating ideas into clinical reality.

Dr Shomron is also the Editor-in-Chief of ‘Genetics Research’ (Cambridge University Press); Director of Rare Genomics Israel a non-profit organization that assists children and families with undiagnosed genetic disorders; Academic Director of ScienceAbroad; and Co-founder of several Biotech companies.

> Full Bio

Dr. Kaplun is among the developers of comprehensive pharmacogenomic database PGMD and other tools and databases aiming to satisfy the growing demand for clinical genomic analysis. He is an author of over 20 peer-reviewed publications.

Before joining Variantyx, Dr Kaplun served as Senior Scientist and Associate Manager of Advanced Genomics at QIAGEN Bioinformatics. During his postdoctoral training he was involved in identification of novel regulatory mechanisms of signal transduction in cancer, factors affecting metastasis and in investigation of longevity mechanisms at Karmanos Cancer Institute. He received his PhD summa cum laude from Ben-Gurion University of the Negev.

> Full Bio

Prior to joining Variantyx, Dr. Shira Modai managed the genomic center of Tel Aviv university. Shira holds a B.Sc in Biotechnology and Food engineering, an M.Sc. in Medical science specializing in Virology and Ph.D. in biology from Tel Aviv University focusing on miRNAs expressed from viral genomes and the interplay with host miRNAs and genes. The Ph.D. thesis was based on the first Next Generation Sequencing runs done in TAU Genomic lab utilizing the Illumina Genome Analyzer IIX sequencer. Shira’s responsibility with Variantyx includes communication with the clinical community (clinicians and hospitals) throughout the lifecycle of a test providing a single point of contact with Variantyx.

   

Tab Content

Nir Pillar

Nir Pillar
MD

Clinical Advisor



> Full Bio

Dr. Pillar attended medical school and completed his residency in the Medical Oncology Department at Sheba Medical Center, Tel HaShomer, Israel. His current Ph.D. research focuses on exploring the deep mechanism of genetic based diseases and the combination of DNA and RNA changes that lead to their development. In his role as Variantyx's Clinical Adviser, he plans and implements novel algorithms for understanding the genetic origin of genetic changes that lead to severe phenotypes. Using analysis and prioritization of genetic variants Dr Pillar is able to correlate these changes to specific diseases.

Ofer Isakov

Ofer Isakov
MD, PhD

Bioinformatic architect

> Full Bio

Dr Isakov attended medical school at Tel Aviv University Sackler School of Medicine and is completing his residency at Tel Aviv Sourasky Medical Center. He received his Ph.D. in Bioinformatics from Tel Aviv University with a focus on development of genetic diagnostic decision-support algorithms based on NGS. Dr Isakov serves as Variantyx's Bioinformatic Pipeline Architect.

David Klein

David Klein

Director of Operations

> Full Bio

David serves as Director of Operations and is responsible for wet bench operations. His role includes qualifying and working with CLIA sequencing companies as well as developing and streamlining new processes. David joined Variantyx with over a decade of experience in planning and executing cross-functional international projects, working with multidisciplinary multicultural teams on time-sensitive assignments. He holds an MBA from Babson's F. W. Olin School of Business and a BA from the Interdisciplinary Center in International Business and Information Systems Management.

> Full bio

Dr. Pillar attended medical school and completed his residency in the Medical Oncology Department at Sheba Medical Center, Tel HaShomer, Israel. His current Ph.D. research focuses on exploring the deep mechanism of genetic based diseases and the combination of DNA and RNA changes that lead to their development. In his role as Variantyx' Clinical Adviser, he plans and implements novel algorithms for understanding the genetic origin of genetic changes that lead to severe phenotypes. Using analysis and prioritization of genetic variants Dr Pillar is able to correlate these changes to specific diseases.

  
  >Full Bio

Dr Isakov attended medical school at Tel Aviv University Sackler School of Medicine and is completing his residency at Tel Aviv Sourasky Medical Center. He received his Ph.D. in Bioinformatics from Tel Aviv University with a focus on development of genetic diagnostic decision-support algorithms based on NGS. Dr Isakov serves as Variantyx's Bioinformatic Pipeline Architect.

        >Full Bio

David serves as Director of Operations and is responsible for wet bench operations. His role includes qualifying and working with CLIA sequencing companies as well as developing and streamlining new processes. David joined Variantyx with over a decade of experience in planning and executing cross-functional international projects, working with multidisciplinary multicultural teams on time-sensitive assignments. He holds an MBA from Babson's F. W. Olin School of Business and a BA from the Interdisciplinary Center in International Business and Information Systems Management.

> Full Bio

Dr. Pillar attended medical school and completed his residency in the Medical Oncology Department at Sheba Medical Center, Tel HaShomer, Israel. His current Ph.D. research focuses on exploring the deep mechanism of genetic based diseases and the combination of DNA and RNA changes that lead to their development. In his role as Variantyx' Clinical Adviser, he plans and implements novel algorithms for understanding the genetic origin of genetic changes that lead to severe phenotypes. Using analysis and prioritization of genetic variants Dr Pillar is able to correlate these changes to specific diseases.

> Full Bio

Dr Isakov attended medical school at Tel Aviv University Sackler School of Medicine and is completing his residency at Tel Aviv Sourasky Medical Center. He received his Ph.D. in Bioinformatics from Tel Aviv University with a focus on development of genetic diagnostic decision-support algorithms based on NGS. Dr Isakov serves as Variantyx's Bioinformatic Pipeline Architect.

> Full Bio

David serves as Director of Operations and is responsible for wet bench operations. His role includes qualifying and working with CLIA sequencing companies as well as developing and streamlining new processes. David joined Variantyx with over a decade of experience in planning and executing cross-functional international projects, working with multidisciplinary multicultural teams on time-sensitive assignments. He holds an MBA from Babson's F. W. Olin School of Business and a BA from the Interdisciplinary Center in International Business and Information Systems Management.

   

Tab Content

Join Us!

We’re always looking for talented and enthusiastic individuals to join our team. Please send your resume and contact information to HumanResources@variantyx.com.

 

Variantyx in an equal opportunity employer.

Variantyx Inc.

1671 Worcester Rd. Framingham MA 01701 USA

E-mail: info@variantyx.com

Phone: +1.617.209.2090

Fax: 508.879.0002

To connect to our Clinical Coordinators, please fill in the following‏
Comments: